Most Clicked StoriesMore >


$15.7B biotech fund proposed by mayor of London

BIO SmartBrief | Jun 26, 2015

A biotech fund worth $15.7 billion was proposed by London Mayor Boris Johnson to finance drug development projects and encourage the growth of biotech companies in the city. "London is one of the most powerful scientific discovery engines in the world. We hope to harness our role as a global financial center that will bring more lifesaving drugs to market and deliver a huge boost to the economy," Johnson said. Bloomberg (06/25) Genetic Engineering & Biotechnology News (06/25)


Celgene, Juno sign $1B collaboration deal

BIO SmartBrief | Jun 30, 2015

Bristol-Myers Squibb ceases antiviral discovery program

BIO SmartBrief | Jun 29, 2015

Rheumatoid arthritis biosimilar drugs termed equivalent

BIO SmartBrief | Jun 26, 2015

Judge rules against biotech crop ban in Maui County

BIO SmartBrief | Jul 01, 2015

Novartis acquires biotech firm Spinifex

BIO SmartBrief | Jun 30, 2015

Drugs from Immunovaccine, Incyte to be combined in cancer trial

BIO SmartBrief | Jun 29, 2015

Etubics to collaborate with National Cancer Institute on cancer immunotherapy

BIO SmartBrief | Jun 25, 2015

Juno's lymphoma drug application accepted by FDA

BIO SmartBrief | Jun 30, 2015

Seres pulls in $134M from IPO

BIO SmartBrief | Jun 29, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


Faster & better connections with quality R&D vendors

BIO SmartBrief | Jul 01, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | Jul 01, 2015

FDA/Sponsor Interactions During Drug Development: Preliminary Data

BIO SmartBrief | Jun 30, 2015

Find the experienced biotech talent that your company needs

BIO SmartBrief | Jun 30, 2015

Secure document sharing services optimized for life science organizations

BIO SmartBrief | Jun 29, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more